• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非肽类激肽受体拮抗剂FR 173657和SSR 240612:治疗皮肤炎症的临床前证据

The non-peptide kinin receptor antagonists FR 173657 and SSR 240612: preclinical evidence for the treatment of skin inflammation.

作者信息

Pietrovski Evelise Fernandes, Otuki Michel Fleith, Regoli Domenico, Bader Michael, Pesquero João Bosco, Cabrini Daniela Almeida, Zampronio Aleksander Roberto

机构信息

Department of Pharmacology, Universidade Federal do Paraná, Curitiba, PR, Brazil.

出版信息

Regul Pept. 2009 Jan 8;152(1-3):67-72. doi: 10.1016/j.regpep.2008.10.005. Epub 2008 Nov 1.

DOI:10.1016/j.regpep.2008.10.005
PMID:18977249
Abstract

Peptide and non-peptide kinin receptor antagonists were evaluated in cutaneous inflammation models in mice. Topical and i.p. application of kinin B(1) and B(2) receptor antagonists caused a significant inhibition of the capsaicin-induced cutaneous neurogenic inflammatory response. The calculated mean ID(50) for Hoe140 and SSR240612 were 23.83 (9.14-62.14) nmol/kg and 0.23 (0.15-0.36) mg/ear, respectively. The I(max) observed for Hoe140, SSR240612, R-715, FR173657, and FR plus SSR were 61+/-5%, 56+/-3%, 65+/-10%, 48+/-8%, and 52+/-4%, respectively. Supporting these results, double B(1) and B(2) kinin receptors knockout mice showed a significant inhibition of capsaicin-induced ear oedema (42+/-7%). However, mice with a single deletion of either B(1) or B(2) receptors exhibited no change in their capsaicin responses. In contrast, all of the examined kinin receptor antagonists were unable to inhibit the oedema induced by TPA and the results from knockout mice confirmed the lack of kinin receptor signaling in this model. These findings show that kinin receptors are present in the skin and that both kinin receptors seem to be important in the neurogenic inflammatory response. Moreover, non-peptide antagonists were very effective in reducing skin inflammation when topically applied, thereby suggesting that they could be useful tools in the treatment of some skin inflammatory diseases.

摘要

在小鼠皮肤炎症模型中对肽类和非肽类激肽受体拮抗剂进行了评估。局部和腹腔注射激肽B(1)和B(2)受体拮抗剂可显著抑制辣椒素诱导的皮肤神经源性炎症反应。计算得出的Hoe140和SSR240612的平均半数抑制剂量(ID50)分别为23.83(9.14 - 62.14)nmol/kg和0.23(0.15 - 0.36)mg/耳。观察到的Hoe140、SSR240612、R - 715、FR173657和FR加SSR的最大抑制率(I(max))分别为61±5%、56±3%、65±10%、48±8%和52±4%。支持这些结果的是,双B(1)和B(2)激肽受体敲除小鼠对辣椒素诱导的耳部水肿有显著抑制作用(42±7%)。然而,单缺失B(1)或B(2)受体的小鼠对辣椒素的反应没有变化。相反,所有检测的激肽受体拮抗剂均无法抑制佛波酯(TPA)诱导的水肿,敲除小鼠的结果证实了该模型中缺乏激肽受体信号传导。这些发现表明皮肤中存在激肽受体,并且两种激肽受体似乎在神经源性炎症反应中都很重要。此外,非肽类拮抗剂局部应用时在减轻皮肤炎症方面非常有效,因此表明它们可能是治疗某些皮肤炎症性疾病的有用工具。

相似文献

1
The non-peptide kinin receptor antagonists FR 173657 and SSR 240612: preclinical evidence for the treatment of skin inflammation.非肽类激肽受体拮抗剂FR 173657和SSR 240612:治疗皮肤炎症的临床前证据
Regul Pept. 2009 Jan 8;152(1-3):67-72. doi: 10.1016/j.regpep.2008.10.005. Epub 2008 Nov 1.
2
B1 and B2 kinin receptor participation in hyperproliferative and inflammatory skin processes in mice.B1 和 B2 激肽受体参与小鼠过度增殖和炎症皮肤过程。
J Dermatol Sci. 2011 Oct;64(1):23-30. doi: 10.1016/j.jdermsci.2011.06.016. Epub 2011 Jul 12.
3
Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease.激肽B(1)和B(2)受体的基因缺失或拮抗作用可改善阿尔茨海默病小鼠模型的认知缺陷。
Neuroscience. 2008 Feb 6;151(3):631-43. doi: 10.1016/j.neuroscience.2007.11.009. Epub 2007 Nov 17.
4
Effect of novel selective non-peptide kinin B(1) receptor antagonists on mouse pleurisy induced by carrageenan.新型选择性非肽类缓激肽B(1)受体拮抗剂对角叉菜胶诱导的小鼠胸膜炎的影响。
Peptides. 2006 Nov;27(11):2967-75. doi: 10.1016/j.peptides.2006.07.007. Epub 2006 Aug 17.
5
TNF-alpha and IL-1beta mediate inflammatory hypernociception in mice triggered by B1 but not B2 kinin receptor.肿瘤坏死因子-α和白细胞介素-1β介导由B1而非B2激肽受体触发的小鼠炎性痛觉过敏。
Eur J Pharmacol. 2007 Nov 14;573(1-3):221-9. doi: 10.1016/j.ejphar.2007.07.007. Epub 2007 Jul 13.
6
The role of kinin B1 and B2 receptors in the scratching behaviour induced by proteinase-activated receptor-2 agonists in mice.激肽 B1 和 B2 受体在蛋白酶激活受体-2 激动剂诱导的小鼠搔抓行为中的作用。
Br J Pharmacol. 2010 Feb;159(4):888-97. doi: 10.1111/j.1476-5381.2009.00571.x. Epub 2010 Jan 8.
7
Roles of kinin B1 and B2 receptors in skin cancer pain produced by orthotopic melanoma inoculation in mice.B1 和 B2 激肽受体在原位接种黑色素瘤诱导的小鼠皮肤癌痛中的作用。
Eur J Pain. 2010 Jul;14(6):588-94. doi: 10.1016/j.ejpain.2009.10.010. Epub 2009 Nov 25.
8
Interactive contribution of NK(1) and kinin receptors to the acute inflammatory oedema observed in response to noxious heat stimulation: studies in NK(1) receptor knockout mice.NK(1)受体和激肽受体对有害热刺激引起的急性炎性水肿的交互作用:NK(1)受体基因敲除小鼠的研究
Br J Pharmacol. 2001 Dec;134(8):1805-13. doi: 10.1038/sj.bjp.0704436.
9
Kinin B(1) and B(2) receptors contribute to orofacial heat hyperalgesia induced by infraorbital nerve constriction injury in mice and rats.激肽 B(1) 和 B(2) 受体参与眶下神经缩窄损伤诱导的小鼠和大鼠口面热痛觉过敏。
Neuropeptides. 2010 Apr;44(2):87-92. doi: 10.1016/j.npep.2009.10.005. Epub 2009 Nov 14.
10
Non-peptide antagonists for kinin B1 receptors: new insights into their therapeutic potential for the management of inflammation and pain.缓激肽B1受体的非肽拮抗剂:对其在炎症和疼痛管理中的治疗潜力的新见解。
Trends Pharmacol Sci. 2006 Dec;27(12):646-51. doi: 10.1016/j.tips.2006.10.007. Epub 2006 Oct 20.

引用本文的文献

1
Recent advances in the discovery and development of drugs targeting the kallikrein-kinin system.靶向激肽释放酶-激肽系统的药物发现与开发的最新进展。
J Transl Med. 2024 Apr 26;22(1):388. doi: 10.1186/s12967-024-05216-5.
2
Bradykinin B1 receptor antagonist protects against cold stress-induced erectile dysfunction in rats.缓激肽B1受体拮抗剂可预防大鼠冷应激诱导的勃起功能障碍。
Sex Med. 2023 Jan 12;11(1):qfac004. doi: 10.1093/sexmed/qfac004. eCollection 2023 Feb.
3
The kallikrein-kinin system as a regulator of cardiovascular and renal function.
激肽释放酶-激肽系统作为心血管和肾功能的调节剂。
Compr Physiol. 2011 Apr;1(2):971-93. doi: 10.1002/cphy.c100053.
4
The kallikrein-kinin system in diabetic nephropathy.糖尿病肾病中的激肽释放酶-激肽系统。
Kidney Int. 2012 Apr;81(8):733-44. doi: 10.1038/ki.2011.499. Epub 2012 Feb 8.
5
Blockade of the kinin B1 receptor ameloriates glomerulonephritis.阻断激肽 B1 受体可减轻肾小球肾炎。
J Am Soc Nephrol. 2010 Jul;21(7):1157-64. doi: 10.1681/ASN.2009090887. Epub 2010 May 6.
6
The role of kinin B1 and B2 receptors in the scratching behaviour induced by proteinase-activated receptor-2 agonists in mice.激肽 B1 和 B2 受体在蛋白酶激活受体-2 激动剂诱导的小鼠搔抓行为中的作用。
Br J Pharmacol. 2010 Feb;159(4):888-97. doi: 10.1111/j.1476-5381.2009.00571.x. Epub 2010 Jan 8.
7
Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors.缓激肽 B1 和 B2 受体对诱导型和内皮型一氧化氮合酶的差异调节。
Neuropeptides. 2010 Apr;44(2):145-54. doi: 10.1016/j.npep.2009.12.004. Epub 2010 Jan 4.